OMEGA-3 FATTY ACID COMPOSITION FOR PREVENTING AND/OR TREATING CACHEXIA

The present invention relates to compositions of polyunsaturated omega-3 fatty such as of (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoicacid (EPA) and (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoicacid (DHA) for preventing and/or treating cachexia in a subject. Particularly, the compos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HUSTVEDT, SVEIN OLAF, WOLD, IDA MARIE, NYHEIM, HILDE, LARSEN, LAILA NORRHEIM
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to compositions of polyunsaturated omega-3 fatty such as of (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoicacid (EPA) and (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoicacid (DHA) for preventing and/or treating cachexia in a subject. Particularly, the compositions comprise a certain amount of the fatty acids as monoacylglycerides. Further, the compositions of omega-3 fatty acids preferably comprise a certain ratio of the fatty acids as mono-, di- and triacylglycerides as this enhances the digestion and uptake of the EPA and DHA fatty acids. Further, the invention relates to a method of preventing and/or treating cachexia in a subject, including administering a composition of EPA and DHA to the subject, wherein at least a part of the fatty acids are provided in monoacylglyceride form. La présente invention concerne des compositions d'acides gras oméga-3 polyinsaturés tels que l'acide (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaénoique (EPA) et l'acide (4Z,7Z,10Z,13Z,116Z,9Z)-docosa-4,7,10,13,16,19-hexaénoïque (DHA) pour prévenir et/ou traiter la cachexie chez un sujet. En particulier, les compositions comprennent une certaine quantité des acides gras sous forme de monoacylglycérides. En outre, les compositions d'acides gras oméga-3 comprennent de préférence un certain rapport des acides gras sous forme de mono -, di- et triacylglycérides, étant donné que cela améliore la digestion et l'absorption des acides gras d'EPA et de DHA. En outre, l'invention concerne un procédé de prévention et/ou traitement de la cachexie chez un sujet, comprenant l'administration d'une composition d'EPA et de DHA au sujet, au moins une partie des acides gras étant fournis sous forme de monoacylglycéride.